Vitamin C is a vitamins supplement. Evidence rating: 3 out of 5. Verdict: Essential nutrient with clear benefits for deficiency prevention. Evidence for mega-dosing to prevent colds is weak, but may modestly reduce duration. Recommended dose: 80–200 mg. Key benefits: Supports collagen production for skin and joints; Enhances immune cell function; Improves non-haem iron absorption; Potent antioxidant protecting against oxidative stress. Backed by 14 peer-reviewed papers. Warnings: High doses (>1000 mg) may cause diarrhoea and nausea; Can increase oxalate levels — caution with kidney stone history; Most people get enough from a balanced diet.

Nutripedia presents published research and does not provide medical advice. Always consult a healthcare professional before starting any supplement.

Research summary

What does the research say about Vitamin C?

Essential nutrient with clear benefits for deficiency prevention. Evidence for mega-dosing to prevent colds is weak, but may modestly reduce duration.

VitaminsEvidence rating 3/514 studies80–200 mg

Summary of published research — not medical advice.

How much Vitamin C is used in clinical trials?

See the evidence tab for dosage ranges observed across clinical studies.

What side effects have been reported?

See the evidence tab for reported adverse effects from published trials.

Which form of Vitamin C has the strongest evidence base?

See the evidence tab for a comparison of studied forms and bioavailability data.

Vitamin C

Mixed Evidence

Antioxidant powerhouse supporting immunity and collagen synthesis.

Vitamins
Tablet
Capsule
Effervescent
Powder
Chewable
Liposomal
Last reviewed: Apr 2026

Not medical advice

Nutripedia summarises published peer-reviewed research. This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before taking any supplement.

Vitamin C (ascorbic acid) is a water-soluble essential vitamin that functions as an antioxidant and cofactor in collagen biosynthesis, immune defence, and non-haem iron absorption. Dietary deficiency causes scurvy; subclinical inadequacy impairs wound healing and immune function. The NHS RNI is 40 mg/day for adults; EFSA population reference intake is 95–110 mg/day. Most UK adults achieve adequacy through diet; specific groups (smokers, those with malabsorption) may have higher requirements.

Verdict
Mixed Evidence

Essential nutrient with well-established EFSA-authorised health claims for immune function, collagen synthesis, antioxidant protection, and iron absorption. The Cochrane evidence base does not support high-dose supplementation for cold prevention in the general population, though modest duration benefits are seen. Evidence for cardiovascular and cancer benefits from supplementation in replete adults is inconsistent.

Evidence rating: 3/5
Top Evidence
A

Non-haem Iron Absorption

14 studies · 520 participants

A

Collagen Synthesis & Wound Healing

10 studies · 680 participants

B

Immune Cell Function & Infection Duration

31 studies · 9,745 participants

View all outcomes

The Evidence

14 peer-reviewed papers, updated 5 days ago

4 meta-analyses · 5 systematic reviews · 3 RCTs · 2 regulatory documents

Regulatory2025

Vitamin C: Health Professional Fact Sheet

National Institutes of Health Office of Dietary Supplements

NIH Office of Dietary Supplements

RDA for adults: 90 mg/day (men), 75 mg/day (women); smokers add 35 mg/day. Tolerable Upper Intake Level: 2,000 mg/day for adults. Cell saturation occurs at ~100 mg/day; plasma increases only marginally above 200 mg/day. High doses may cause gastrointestinal disturbance. Vitamin C is essential for collagen synthesis, immune function, and iron absorption.

Systematic review2025

Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential

Alberts A, Moldoveanu ET, Niculescu AG et al.

Molecules

Vitamin C functions as a cofactor in collagen and hormone synthesis and is involved in immunity, iron absorption, and antioxidant processes. Pharmacological-dose IV administration shows promise in cancer and sepsis. Contradictory findings in oral supplementation trials highlight the need for larger, longer-duration studies across chronic disease indications.

Meta-analysis2023

Vitamin C reduces the severity of common colds: a meta-analysis

Hemilä H, Chalker E

BMC Public Health

Analysis of 15 comparisons from 10 double-blind RCTs found vitamin C supplementation reduced common cold severity by 15% compared to placebo. Effects were more pronounced for severe symptom presentations than mild cases, with clinical relevance for work and school absenteeism.

Meta-analysis2022

Association of Vitamin C Treatment with Clinical Outcomes for COVID-19 Patients: A Systematic Review and Meta-Analysis

Huang WY, Hong J, Ahn SI et al.

Healthcare (Basel)

Meta-analysis of 19 studies (949 vitamin C recipients, 1,816 controls) found a trend toward lower COVID-19 mortality (RR 0.81, 95% CI 0.62–1.07) that did not reach statistical significance. No significant differences in ventilation incidence, hospitalisation duration, or ICU stay. Larger trials are needed.

Systematic review2022

A Systematic Review on the Role of Vitamin C in Tissue Healing

Bechara N, Flood VM, Gunton JE

Antioxidants (Basel)

Vitamin C supplementation improved wound healing outcomes, predominantly for pressure ulcers, acting as a cofactor for prolyl and lysyl hydroxylases essential in collagen triple-helix formation and as an antioxidant reducing ROS-driven cell apoptosis during inflammation. Evidence quality was limited by small samples and multi-nutrient designs.

Systematic review2021

Vitamin C supplementation for prevention and treatment of pneumonia

Padhani ZA, Moazzam Z, Ashraf A et al.

Cochrane Database of Systematic Reviews

Five studies (2,655 participants) were insufficient to determine whether vitamin C prevents or treats pneumonia. Evidence certainty rated very low due to small sample sizes and high risk of bias. Further high-quality RCTs are required before clinical recommendations can be made.

RCT2021

Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability

Gopi S, Balakrishnan P

Journal of Liposome Research

Liposomal oral vitamin C was 1.77 times more bioavailable than standard oral ascorbic acid, with particle sizes below 100 nm and 65.85% encapsulation efficiency. Liposomal delivery produced measurably higher peak plasma concentrations and total exposure, enabling meaningful increases in systemic vitamin C without exceeding gastrointestinal tolerance.

Meta-analysis2017

The regulation of dietary iron bioavailability by vitamin C: a systematic review and meta-analysis

Heffernan A, Evans C, Holmes M et al.

Proceedings of the Nutrition Society

Meta-analysis of short-term studies (n=315) demonstrated highly significant increases in non-haem iron absorption when ascorbic acid was co-ingested with test meals. Long-term supplementation (5 studies, n=118) also significantly raised haemoglobin. Authors conclude increasing vitamin C intake is a practical strategy to reduce iron deficiency risk.

Systematic review2017

Vitamin C and Immune Function

Carr AC, Maggini S

Nutrients

Vitamin C accumulates in neutrophils and macrophages, supports epithelial barrier integrity, promotes phagocytosis and reactive oxygen species generation, and facilitates lymphocyte differentiation. Prophylactic benefit requires 100–200 mg/day; treatment of established infections may require gram-level doses. Deficiency compromises immune competence.

Systematic review2017

Vitamin C and Infections

Hemilä H

Nutrients

Vitamin C halved cold incidence in physically active people and shortened duration in the general population. Three controlled trials showed prevention of pneumonia; two showed treatment benefit. A dose-response was seen at 6–8 g/day for cold duration. 148 animal studies support broader anti-infective properties.

Regulatory2013

Scientific Opinion on Dietary Reference Values for Vitamin C

EFSA Panel on Dietetic Products Nutrition and Allergies (NDA)

EFSA Journal

EFSA established Population Reference Intakes (PRIs) of 110 mg/day for adult men and 95 mg/day for adult women, targeting plasma near-saturation at ~50 µmol/L. No tolerable upper intake level was set due to insufficient evidence of adverse effects at high intakes. Smokers require higher intakes to achieve equivalent plasma levels.

Meta-analysis2013

Vitamin C for preventing and treating the common cold

Hemilä H, Chalker E

Cochrane Database of Systematic Reviews

Regular vitamin C supplementation (≥200 mg/day) does not reduce cold incidence in the general population but modestly reduces duration (8% in adults, 14% in children). In athletes under extreme physical stress, vitamin C halved cold risk. Therapeutic dosing after symptom onset showed no consistent benefit.

RCT2004

Vitamin C pharmacokinetics: implications for oral and intravenous use

Padayatty SJ, Sun H, Wang Y et al.

Annals of Internal Medicine

Oral vitamin C is tightly controlled by intestinal absorption and renal reabsorption; a 1.25 g oral dose achieved peak plasma of ~135 µmol/L versus ~885 µmol/L intravenously. Only intravenous administration produces pharmacological concentrations potentially relevant to antitumour activity. Prior oral-only cancer trials were therefore pharmacologically inadequate.

RCT1996

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance

Levine M, Conry-Cantilena C, Wang Y et al.

Proceedings of the National Academy of Sciences USA

Vitamin C exhibits sigmoid pharmacokinetics: plasma becomes fully saturated at 1,000 mg/day. Bioavailability is near complete at doses up to 200 mg but decreases at higher intakes. The authors recommended raising the RDA to 200 mg/day, achievable through diet. Safe daily dose defined as below 1,000 mg.

Evidence Database

Click any row to explore the studies behind each health outcome. Grades reflect the volume and quality of published research, not a recommendation.

GradeHealth Outcome
A
Non-haem Iron Absorption14 studies
A
Collagen Synthesis & Wound Healing10 studies
B
Immune Cell Function & Infection Duration31 studies
B
Oxidative Stress & Antioxidant Status22 studies
C
Blood Pressure8 studies

Supplier Directory

Verified UK retailers ranked by trust and transparency. Certification badges show which quality standards each supplier meets.

Myprotein

Brand Direct
Trust: 4/5
2–4 working days
Free over £25
Free next-day over £45
UK
Informed SportNSF Certified for SportCreapureGMP Certified

Bulk

Brand Direct
Trust: 4/5
1–3 working days
Free over £35
UK
Informed SportNSF Certified for SportCreapureGMP Certified

Amazon UK

Marketplace
Trust: 3/5
1–2 days (Prime)
Free delivery with Prime
UK
Informed SportNSF Certified for SportCreapureGMP Certified

Holland & Barrett

Health Store
Trust: 5/5
3–5 working days
Free over £20
UK
Informed SportNSF Certified for SportCreapureGMP Certified

Thorne

Brand Direct
Trust: 5/5
5–10 working days
Free over £50
Ships from US
International
Informed SportNSF Certified for SportCreapureGMP Certified

Cost Comparison

Top 5 cheapest options by daily cost. Click column headers to re-sort. Prices in GBP.

Format:
Form
No products found for this format.

General Information

Dosage (Evidence-Reported)

Studies typically used80–200 mg
With meals
NHS RNI: 40 mg/day. EFSA population reference intake: 95–110 mg/day. Plasma saturation occurs at approximately 200–400 mg/day. Cochrane cold trials studied doses of 200–2000 mg/day. NHS advises not exceeding 1000 mg/day from supplements.

These figures reflect what clinical studies used — not personalised recommendations.

Safety Notes

  • Doses above 1000 mg/day commonly reported to cause GI adverse events (diarrhoea, nausea)
  • High-dose supplementation increases urinary oxalate — caution with history of kidney stones
  • Cochrane evidence does not support cold prevention in general population
  • Most healthy UK adults achieve adequacy through diet alone

Key Benefits

  • Essential cofactor for collagen synthesis — bone, skin, gum, blood vessel integrity
  • Enhances non-haem iron absorption up to 4-fold when co-ingested
  • Potent aqueous antioxidant — regenerates vitamin E
  • Reduces cold duration modestly in clinical trial data (8% adults, 14% children)
  • Supports immune cell function; EFSA-authorised claim

Quick Facts

Also known as
Ascorbic acid
L-Ascorbic acid
Sodium ascorbate
Calcium ascorbate
Ascorbate
Available forms
Tablet
Capsule
Effervescent
Powder
Chewable
Liposomal
Regulatory status

Legal food supplement (UK). Multiple EFSA-authorised health claims for immune function, collagen formation, antioxidant protection, iron absorption, energy metabolism, and reduction of tiredness and fatigue.

Frequently Asked Questions

Nutripedia is an educational resource. Content is sourced from peer-reviewed studies and does not constitute medical advice. Consult a healthcare professional before starting any supplement.

Reviewed by

Archie Roberts

Founder, Nutripedia — ALDR Ltd

This page summarises published research from PubMed, NHS, EFSA, and SACN. It does not constitute medical advice; consult a qualified healthcare professional before changing any supplement regimen.

Last reviewed: 20 Apr 2026Methodology